Cargando…
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872189/ https://www.ncbi.nlm.nih.gov/pubmed/36704752 http://dx.doi.org/10.3389/falgy.2022.1119941 |
_version_ | 1784877351425802240 |
---|---|
author | López-Viña, Antolín Diaz Campos, Rocio M. Trisan Alonso, Andrea Melero Moreno, Carlos |
author_facet | López-Viña, Antolín Diaz Campos, Rocio M. Trisan Alonso, Andrea Melero Moreno, Carlos |
author_sort | López-Viña, Antolín |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9872189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98721892023-01-25 Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach López-Viña, Antolín Diaz Campos, Rocio M. Trisan Alonso, Andrea Melero Moreno, Carlos Front Allergy Allergy Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9872189/ /pubmed/36704752 http://dx.doi.org/10.3389/falgy.2022.1119941 Text en © 2023 López-Viña, Díaz Campos, Trisan Alonso and Melero Moreno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Allergy López-Viña, Antolín Diaz Campos, Rocio M. Trisan Alonso, Andrea Melero Moreno, Carlos Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach |
title | Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach |
title_full | Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach |
title_fullStr | Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach |
title_full_unstemmed | Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach |
title_short | Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach |
title_sort | corrigendum: uncontrolled severe t2 asthma: which biological to choose? a biomarker-based approach |
topic | Allergy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872189/ https://www.ncbi.nlm.nih.gov/pubmed/36704752 http://dx.doi.org/10.3389/falgy.2022.1119941 |
work_keys_str_mv | AT lopezvinaantolin corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach AT diazcamposrociom corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach AT trisanalonsoandrea corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach AT meleromorenocarlos corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach |